MedDataX Logo

Massive Mental Health Screening Using Smartphones in 24 Pre-graduate Education Centers in Mexico City: TEDUCA Survey Protocol

NCT04067076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2020-07-07

No results posted yet for this study

Summary

The objective of this study is to make a massive suicide risk and social behavior assessment in 24 pre-graduate education centers in Mexico City (approximately 30,000 students aged between 15 and 22 years), taking also into account other outcomes such as depression, anxiety, alcohol and drugs. For this, an app for Smartphone (MeMind) or a web platform (www.MeMind.net) will be used in which the participants will take a self-administered questionnaire, composed of several psychometric instruments.

Our main hypothesis is that identification of suicide risk in the Mexico City's student community is feasible using their own smartphones and can serve as both a population screening tool for early specialist referral, as well as a tool for evaluating social behavior strategies and their relation to suicide behavior.

Conditions

  • Suicidal Ideation
  • Social Behavior
  • Depression
  • Depressive Disorder
  • Anxiety
  • Alcohol Drinking
  • Drug Abuse

Interventions

OTHER

Self-administered evaluation questionnaire

Smartphone app with MeMind questionnaires

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER

  • Instituciones Educativas de nivel Medio Superior (IEMS) de Ciudad de México

    collaborator UNKNOWN

  • Gobierno de la Ciudad de Mexico

    collaborator UNKNOWN

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-26
Primary Completion
2020-07-31
Completion
2020-08-31

Countries

  • Mexico

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04067076 on ClinicalTrials.gov